The drug is also indicated for obesity-related to proopiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1 (PCSK1), or leptin receptor (LEPR) deficiency. This evidence concerns the gene LEPR and obesity due to melanocortin 4 receptor deficiency.